These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 2973142)
1. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons. Kelland MD; Freeman AS; Chiodo LA Synapse; 1988; 2(4):416-23. PubMed ID: 2973142 [TBL] [Abstract][Full Text] [Related]
2. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
3. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
4. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study. Kelland MD; Freeman AS; LeWitt PA; Chiodo LA J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800 [TBL] [Abstract][Full Text] [Related]
5. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
6. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration. Kelland MD; Freeman AS; Chiodo LA Synapse; 1989; 3(1):30-7. PubMed ID: 2919369 [TBL] [Abstract][Full Text] [Related]
7. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L Synapse; 1990; 5(2):113-9. PubMed ID: 2137942 [TBL] [Abstract][Full Text] [Related]
9. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus. Carlson JH; Bergstrom DA; Demo SD; Walters JR Synapse; 1990; 5(2):83-93. PubMed ID: 2309160 [TBL] [Abstract][Full Text] [Related]
10. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses. Weick BG; Walters JR Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219 [TBL] [Abstract][Full Text] [Related]
11. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Carlson JH; Bergstrom DA; Weick BG; Walters JR Synapse; 1987; 1(5):411-6. PubMed ID: 2975067 [TBL] [Abstract][Full Text] [Related]
12. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons. Ruskin DN; Bergstrom DA; Walters JR J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. Huang KX; Walters JR J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456 [TBL] [Abstract][Full Text] [Related]
14. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. Huang KX; Walters JR J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat. Freeman AS; Kelland MD; Rouillard C; Chiodo LA J Pharmacol Exp Ther; 1989 Jun; 249(3):790-7. PubMed ID: 2567352 [TBL] [Abstract][Full Text] [Related]
16. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT; White FJ Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat. Clark D; Chiodo LA Synapse; 1988; 2(5):474-85. PubMed ID: 2903568 [TBL] [Abstract][Full Text] [Related]